13F filer · CIK 1422849 ↗
Capital World Investors
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$470.72B
−19% on the quarter before
Positions
563
31 new · 48 sold out
Top 10
28.8%
of the value
Est. gain
−$93.19B
on stocks held all quarter
Est. return
−17.6%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 43% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Eli Lilly~$2.07BAdded · 1.1% → 2.0%+6,384,202 shares
- Cenovus Energy Inc~$1.79BAdded · 0.1% → 0.5%+94,033,331 shares
- Pfizer Inc~$1.59BAdded · 2.0% → 2.8%+30,250,912 shares
- Visa Inc.~$1.39BAdded · 0.0% → 0.3%+7,050,178 shares
- Caterpillar Inc~$1.25BAdded · 0.8% → 1.0%+6,995,910 shares
- D R Horton Inc~$991.6MAdded · 0.2% → 0.5%+14,980,851 shares
- Target Corp~$925.6MAdded · 0.3% → 0.5%+6,553,688 shares
- Canadian Nat Res Ltd~$830.3MAdded · 1.3% → 1.6%+15,452,821 shares
- Corteva Inc~$784.0MAdded · 0.1% → 0.3%+14,481,489 shares
- Northrop Grumman Corp~$777.2MAdded · 0.1% → 0.2%+1,623,944 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$4.13BCut · 6.7% → 4.3%−6,131,990 shares
- Microsoft~$1.51BCut · 5.6% → 5.4%−5,881,538 shares
- Altria Group Inc~$1.11BCut · 1.0% → 0.8%−26,636,610 shares
- Lockheed Martin Corp~$1.04BCut · 1.2% → 1.2%−2,424,359 shares
- BlackRock~$978.3MCut · 0.6% → 0.4%−1,606,174 shares
- Dollar Gen Corp New~$959.8MCut · 0.6% → 0.7%−3,910,691 shares
- Comcast Corp New~$947.6MCut · 0.9% → 0.7%−24,148,781 shares
- Mondelez Intl Inc~$910.2MCut · 0.3% → 0.2%−14,658,980 shares
- Broadcom~$889.9MCut · 3.6% → 3.3%−1,831,660 shares
- Gen Digital~$876.4MCut · 0.2% → 0.1%−39,911,111 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −5.6% · price −16.7% | 5.4% | $25.38B | −$5.09B | ||||||||
| TeslaCOM · shares −17% · price −37.5% | 4.3% | $20.32B | −$12.19B | ||||||||
| Unitedhealth Group IncCOM · shares −2.0% · price +0.7% | 3.7% | $17.53B | +$124.6M | ||||||||
| BroadcomCOM · shares −5.5% · price −22.8% | 3.3% | $15.36B | −$4.55B | ||||||||
| Pfizer IncCOM · shares +14% · price +1.3% | 2.8% | $13.11B | +$144.4M | ||||||||
| Home Depot IncCOM · shares +0.6% · price −8.4% | 2.4% | $11.08B | −$1.01B | ||||||||
| Eli LillyCOM · shares +29% · price +13.2% | 2.0% | $9.32B | +$846.4M | ||||||||
| Philip Morris Intl IncCOM · shares +3.4% · price +5.1% | 1.7% | $8.21B | +$385.6M | ||||||||
| Thermo Fisher Scientific IncCOM · shares −1.3% · price −8.0% | 1.6% | $7.60B | −$662.8M | ||||||||
| Canadian Nat Res LtdCOM · shares +12% · price −13.2% | 1.6% | $7.52B | −$1.02B | ||||||||
| AlphabetCAP STK CL C · shares +0.5% · price −21.7% | 1.5% | $6.91B | −$1.90B | ||||||||
| Cme Group IncCOM · shares +0.04% · price −13.9% | 1.4% | $6.77B | −$1.10B | ||||||||
| MetaCL A · shares −6.9% · price −27.5% | 1.3% | $6.19B | −$2.35B | ||||||||
| Lockheed Martin CorpCOM · shares −15% · price −2.6% | 1.2% | $5.85B | −$155.9M | ||||||||
| Cvs Health CorpCOM · shares +0.3% · price −8.4% | 1.2% | $5.45B | −$501.4M | ||||||||
| Caterpillar IncCOM · shares +35% · price −19.8% | 1.0% | $4.85B | −$886.5M | ||||||||
| AlphabetCAP STK CL A · shares −1.0% · price −21.6% | 0.95% | $4.46B | −$1.23B | ||||||||
| Jpmorgan Chase & CoCOM · shares −13% · price −17.4% | 0.94% | $4.42B | −$931.1M | ||||||||
| AppleCOM · shares +16% · price −21.7% | 0.86% | $4.05B | −$967.6M | ||||||||
| Centene Corp DelCOM · shares −5.9% · price +0.5% | 0.85% | $4.02B | +$20.0M | ||||||||
| Pioneer Nat Res CoCOM · shares +13% · price −10.8% | 0.84% | $3.94B | −$422.7M | ||||||||
| L3harris Technologies IncCOM · shares +5.7% · price −2.7% | 0.81% | $3.84B | −$101.9M | ||||||||
| Regeneron PharmaceuticalsCOM · shares +4.8% · price −15.4% | 0.78% | $3.69B | −$638.3M | ||||||||
| Altria Group IncCOM · shares −24% · price −20.1% | 0.76% | $3.57B | −$895.8M | ||||||||
| Vertex Pharmaceuticals IncCOM · shares −0.8% · price +8.0% | 0.75% | $3.54B | +$261.7M | ||||||||
| Total · 563 positions | 100% | $470.72B | −$93.19B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 526 stocks held throughout, down $93.19B (−17.6%).
- Eli Lilly+$846.4M+13%
- Philip Morris Intl Inc+$385.6M+5%
- Dollar Gen Corp New+$295.8M+10%
- Vertex Pharmaceuticals Inc+$261.7M+8%
- Cigna Corp New+$249.3M+10%
- Meta−$2.35B−27%
- Amazon15:1 split−$3.34B−51%
- Broadcom−$4.55B−23%
- Microsoft−$5.09B−17%
- Tesla−$12.19B−38%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 3 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $846.43B+15% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $732.94B−0% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $735.30B+0% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $732.04B+6% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $687.95B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $617.20B−6% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $658.71B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $645.05B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $613.27B+1% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $604.23B+7% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $562.26B+11% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $504.81B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $519.91B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $483.79B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $469.11B+5% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $445.41B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $470.72B−19% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $580.76B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $632.21B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $585.85B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $588.43B+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $541.07B+4% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $518.94B+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $456.91B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $413.27B+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $344.62B−23% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $447.39B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $415.21B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $426.29B+3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $412.39B+12% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $369.11B−10% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $411.05B−12% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $467.29B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $444.21B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $461.25B+4% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $441.49B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $425.76B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $418.31B+5% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $397.60B+3% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $384.55B+4% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $370.85B+2% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $361.93B | SEC ↗ |